Standard
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy. / Sorensen, P Soelberg; Koch-Henriksen, Nils; Ross, C; Clemmesen, K M; Bendtzen, K; Danish Multiple Sclerosis Study Group.
I:
Neurology, Bind 65, Nr. 1, 12.07.2005, s. 33-9.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Sorensen, PS, Koch-Henriksen, N
, Ross, C, Clemmesen, KM, Bendtzen, K & Danish Multiple Sclerosis Study Group 2005, '
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy',
Neurology, bind 65, nr. 1, s. 33-9.
https://doi.org/10.1212/01.WNL.0000166049.51502.6AAPA
Sorensen, P. S., Koch-Henriksen, N.
, Ross, C., Clemmesen, K. M., Bendtzen, K., & Danish Multiple Sclerosis Study Group (2005).
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Neurology,
65(1), 33-9.
https://doi.org/10.1212/01.WNL.0000166049.51502.6AVancouver
Sorensen PS, Koch-Henriksen N
, Ross C, Clemmesen KM, Bendtzen K, Danish Multiple Sclerosis Study Group.
Appearance and disappearance of neutralizing antibodies during interferon-beta therapy.
Neurology. 2005 jul. 12;65(1):33-9.
https://doi.org/10.1212/01.WNL.0000166049.51502.6AAuthor
Sorensen, P Soelberg ; Koch-Henriksen, Nils ; Ross, C ; Clemmesen, K M ; Bendtzen, K ; Danish Multiple Sclerosis Study Group. / Appearance and disappearance of neutralizing antibodies during interferon-beta therapy. I: Neurology. 2005 ; Bind 65, Nr. 1. s. 33-9.
Bibtex
@article{fcea211250304d0eb8334c3f0eb4d5b9,
title = "Appearance and disappearance of neutralizing antibodies during interferon-beta therapy",
abstract = "Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.",
author = "Sorensen, {P Soelberg} and Nils Koch-Henriksen and C Ross and Clemmesen, {K M} and K Bendtzen and Clemmesen, {Katja Maria}",
year = "2005",
month = jul,
day = "12",
doi = "http://dx.doi.org/10.1212/01.WNL.0000166049.51502.6A",
language = "English",
volume = "65",
pages = "33--9",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams & Wilkins",
number = "1",
}
RIS
TY - JOUR
T1 - Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
AU - Sorensen, P Soelberg
AU - Koch-Henriksen, Nils
AU - Ross, C
AU - Clemmesen, K M
AU - Bendtzen, K
AU - Danish Multiple Sclerosis Study Group
PY - 2005/7/12
Y1 - 2005/7/12
N2 - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
AB - Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
U2 - http://dx.doi.org/10.1212/01.WNL.0000166049.51502.6A
DO - http://dx.doi.org/10.1212/01.WNL.0000166049.51502.6A
M3 - Journal article
VL - 65
SP - 33
EP - 39
JO - Neurology
JF - Neurology
SN - 0028-3878
IS - 1
ER -
